These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29501566)

  • 1. The IRF9-SIRT1-P53 axis is involved in the growth of human acute myeloid leukemia.
    Tian WL; Guo R; Wang F; Jiang ZX; Tang P; Huang YM; Sun L
    Exp Cell Res; 2018 Apr; 365(2):185-193. PubMed ID: 29501566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF3 is involved in human acute myeloid leukemia through regulating the expression of miR-155.
    Tian WL; Jiang ZX; Wang F; Guo R; Tang P; Huang YM; Sun L
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1130-5. PubMed ID: 27530922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative Regulation of SIRT1 by IRF9 Involved in Hyperlipidemia Acute Pancreatitis Associated with Kidney Injury.
    Liu Y; Sun Y; Xue BH; Wang XD; Yu WL
    Dig Dis Sci; 2021 Apr; 66(4):1063-1071. PubMed ID: 32462510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF9 promotes apoptosis and innate immunity by inhibiting SIRT1-p53 axis in fish.
    Jiang Z; Weng P; Xu X; Li M; Li Y; Lv Y; Chang K; Wang S; Lin G; Hu C
    Fish Shellfish Immunol; 2020 Aug; 103():220-228. PubMed ID: 32439513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF2-INPP4B axis participates in the development of acute myeloid leukemia by regulating cell growth and survival.
    Zhang F; Zhu J; Li J; Zhu F; Zhang P
    Gene; 2017 Sep; 627():9-14. PubMed ID: 28579269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel function of IRF9 in acute pancreatitis by modulating cell apoptosis, proliferation, migration, and suppressing SIRT1-p53.
    Xue BH; Liu Y; Chen H; Sun Y; Yu WL
    Mol Cell Biochem; 2020 Sep; 472(1-2):125-134. PubMed ID: 32577948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia.
    Sasca D; Hähnel PS; Szybinski J; Khawaja K; Kriege O; Pante SV; Bullinger L; Strand S; Strand D; Theobald M; Kindler T
    Blood; 2014 Jul; 124(1):121-33. PubMed ID: 24855208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minicircuitry comprised of microRNA-9 and SIRT1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Zhou L; Fu L; Lv N; Chen XS; Liu J; Li Y; Xu QY; Huang S; Zhang XD; Dou LP; Wang LL; Li YH; Yu L
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):786-794. PubMed ID: 28272704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury.
    Zhang Y; Liu X; She ZG; Jiang DS; Wan N; Xia H; Zhu XH; Wei X; Zhang XD; Li H
    Basic Res Cardiol; 2014; 109(5):434. PubMed ID: 25150882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
    Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
    Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
    De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
    Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role for interferon regulatory factor 9 in cerebral ischemic stroke.
    Chen HZ; Guo S; Li ZZ; Lu Y; Jiang DS; Zhang R; Lei H; Gao L; Zhang X; Zhang Y; Wang L; Zhu LH; Xiang M; Zhou Y; Wan Q; Dong H; Liu DP; Li H
    J Neurosci; 2014 Sep; 34(36):11897-912. PubMed ID: 25186738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LGALS1 acts as a pro-survival molecule in AML.
    Ruvolo PP; Ma H; Ruvolo VR; Zhang X; Post SM; Andreeff M
    Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118785. PubMed ID: 32590026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.
    Abramowitz J; Neuman T; Perlman R; Ben-Yehuda D
    BMC Med Genomics; 2017 Mar; 10(1):18. PubMed ID: 28340577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontoxic-dose of deguelin induce NPMc+ AML cell differentiation by selectively targeting Mt NPM1/SIRT1 instead of HDAC1/3.
    Wang YP; Yi S; Wen L; Zhang BP; Zhao Z; Hu JY; Zhao F; He J; Fang J; Zhang C; Cui G; Chen Y
    Curr Cancer Drug Targets; 2014; 14(8):685-99. PubMed ID: 25348016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.
    Ruvolo PP; Ruvolo VR; Benton CB; AlRawi A; Burks JK; Schober W; Rolke J; Tidmarsh G; Hail N; Davis RE; Andreeff M
    Biochim Biophys Acta; 2016 Apr; 1863(4):562-71. PubMed ID: 26704388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia.
    Seipel K; Marques MT; Bozzini MA; Meinken C; Mueller BU; Pabst T
    Clin Cancer Res; 2016 Feb; 22(3):746-56. PubMed ID: 26408402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.
    Hartman AD; Wilson-Weekes A; Suvannasankha A; Burgess GS; Phillips CA; Hincher KJ; Cripe LD; Boswell HS
    Exp Hematol; 2006 Oct; 34(10):1360-76. PubMed ID: 16982329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway.
    Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L
    Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.